Global Acne Treatment Market Revenue is Estimated to Reach USD 9,138.04 million by 2031, Growing at a CAGR of 5.13%: Straits Research
February 08, 2024 10:10 ET
|
Reed Intelligence
New York, United States, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Acne is a skin condition that results from clogged skin openings and pores, including hair follicles. Most people who tend to follow this...
Complicated Skin and Skin Structure Infections (cSSSI) Drugs Market is Expected to Reach the Valuation of USD 18.65 Billion by 2030, Size, Share, Growth, Trends, Demand and Opportunity Analysis
May 17, 2023 12:30 ET
|
Data Bridge Market Research
PHILADELPHIA, May 17, 2023 (GLOBE NEWSWIRE) -- The newest report from Data Bridge Market Research, "Complicated Skin and Skin Structure Infections (cSSSI) Drugs Market" examines growth strategies,...
Incannex Appoints QPS to Advance CannQuit-N™ (Nicotine), CannQuit-O™ (Opioid) and Renecann™ Products in the USA and EU
April 14, 2023 07:30 ET
|
Incannex Healthcare
MELBOURNE, Australia, April 14, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Ltd (Nasdaq: IXHL) (ASX: IHL) (‘Incannex’ or ‘the Company’) a pharmaceutical company developing proprietary medicinal...
Dermatology OTC Medications Market Worth $21.31Bn, Globally, by 2028 at 4.7% CAGR - Exclusive Report by The Insight Partners
March 25, 2022 06:46 ET
|
The Insight Partners
New York, March 25, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Dermatology OTC Medications Market Forecast to 2028 - COVID-19 Impact and Global Analysis By...
Enhanced Exposure to Cosmetic Products Increases Possibilities of Atopic Dermatitis; Global Atopic Dermatitis Drug Sales are Expected to reach US$ 21 billion by 2031
July 13, 2021 08:30 ET
|
insightSLICE
PUNE, India., July 13, 2021 (GLOBE NEWSWIRE) -- The Global Atopic Dermatitis Drug Market Share, Trends, Analysis and Forecasts, 2020-2030 provides insights on key developments, business strategies,...
Phototherapy Market To Reach USD 717.3 Million By 2026 | Reports And Data
July 15, 2019 08:15 ET
|
Reports and Data
New York, July 15, 2019 (GLOBE NEWSWIRE) -- The continuous rise in incidences of neonatal jaundice in both developed and developing markets, rising number of people suffering from skin diseases,...
Newly Published Nonclinical Data Highlight the Role of Olumacostat Glasaretil in Sebum Inhibition
June 26, 2017 07:30 ET
|
Dermira, Inc.
MENLO PARK, Calif., June 26, 2017 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering...
Dermira Announces Appointment of Ian Clements as Vice President, Investor Relations
June 06, 2017 07:30 ET
|
Dermira, Inc.
MENLO PARK, Calif., June 06, 2017 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering...
Dermira to Present at Jefferies 2017 Global Healthcare Conference
May 30, 2017 16:05 ET
|
Dermira, Inc.
MENLO PARK, Calif., May 30, 2017 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering...
Dermira Announces Closing of 3.00% Convertible Senior Notes Offering
May 16, 2017 16:01 ET
|
Dermira, Inc.
MENLO PARK, Calif., May 16, 2017 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM) announced today the closing of its previously announced offering of 3.00% Convertible Senior Notes due 2022 (the...